Genmab

scrapheap
Biotech

Genmab sheds another clinical ADC from $1.8B ProfoundBio buy

The Danish pharma dropped GEN1160 after poor enrollment in a phase 1/2 cancer trial.
Darren Incorvaia Nov 17, 2025 2:17pm
MA strategy deal block push come together form

Genmab pays $8B to buy Merus and phase 3 bispecific

Sep 29, 2025 5:38am
RD oil pipeline

Genmab discards ADC from $1.8B ProfoundBio buy

Sep 16, 2025 10:33am
parachutes sky italy sun blue

Pfizer’s reputation wrangler plans departure—Chutes & Ladders

Jul 11, 2025 8:30am
An arrow incrementally going up stairs before pointing straight up Blue background

Endometrial cancer data on Genmab's Elahere rival beat forecast

May 23, 2025 9:22am
Manila folder with CONFIDENTIAL printed on it in red

AbbVie alleges Genmab 'willfully blind' to trade secret theft

Mar 24, 2025 5:51am